Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Verification and comparison of pig, mouse, and human genome similarities: use of manual assembly and analyses.

BMC genomics·2025
Same author

Altered structural and transporter-related gene expression patterns in the placenta play a role in fetal demise during Porcine reproductive and respiratory syndrome virus infection.

BMC genomics·2025
Same author

Production and characterization of anti-porcine CXCL10 monoclonal antibodies.

Cytokine·2023
Same author

Genome wide association study of thyroid hormone levels following challenge with porcine reproductive and respiratory syndrome virus.

Frontiers in genetics·2023
Same author

Development and Characterization of New Monoclonal Antibodies Against Porcine Interleukin-17A and Interferon-Gamma.

Frontiers in immunology·2022
Same author

The Natural Cytotoxicity Receptor NKp44 (NCR2, CD336) Is Expressed on the Majority of Porcine NK Cells <i>Ex Vivo</i> Without Stimulation.

Frontiers in immunology·2022

Related Experiment Video

Updated: May 10, 2026

Nasal Wipes for Influenza A Virus Detection and Isolation from Swine
05:59

Nasal Wipes for Influenza A Virus Detection and Isolation from Swine

Published on: December 4, 2015

9.5K

Progress and challenges in developing swine immune reagents.

Joan K Lunney1

  • 1Animal Parasitic Diseases Laboratory, BARC, ARS, USDA, Beltsville, MD, USA.

Veterinary Immunology and Immunopathology
|July 11, 2025
PubMed
Summary

High-quality swine immune reagents, including antibodies and proteins, are crucial for understanding infectious disease and vaccine responses. Ensuring their continued availability requires addressing production and characterization challenges for researchers.

Keywords:
CD (cluster of differentiation) markersCommercial availabilityImmune cellsMonoclonal antibodiesRepositories

More Related Videos

Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies
05:27

Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies

Published on: January 26, 2019

23.8K
Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

21.9K

Related Experiment Videos

Last Updated: May 10, 2026

Nasal Wipes for Influenza A Virus Detection and Isolation from Swine
05:59

Nasal Wipes for Influenza A Virus Detection and Isolation from Swine

Published on: December 4, 2015

9.5K
Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies
05:27

Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies

Published on: January 26, 2019

23.8K
Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

21.9K

Area of Science:

  • Veterinary immunology
  • Swine research
  • Infectious disease mechanisms

Background:

  • Swine immune reagents are essential for studying immune responses to diseases and vaccines.
  • Availability of antibodies and immune proteins is key for analyzing cellular and tissue interactions.
  • Challenges exist in maintaining a comprehensive panel of these vital research tools.

Purpose of the Study:

  • To review the availability of swine immune reagents.
  • To highlight issues affecting the supply of antibodies and immune proteins.
  • To suggest future directions for improving the swine research toolkit.

Main Methods:

  • Literature review on swine immune reagent availability.
  • Discussion of challenges in production and characterization.
  • Analysis of reagent accessibility for the research community.

Main Results:

  • Current availability of swine antibodies and immune proteins is reviewed.
  • Key issues in the production, characterization, and availability of reagents are identified.
  • Challenges related to monoclonal antibodies (mAbs) and cluster of differentiation (CD) markers are discussed.

Conclusions:

  • Continued availability of swine immune reagents is critical for advancing research.
  • Addressing production and characterization issues is necessary to ensure a robust research toolkit.
  • Future investments are recommended to support the development and accessibility of these essential reagents.